abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
SG&A Expenses
$3.29M
Quarterly · Period ending: · USD
HQL SG&A Expenses
Latest reported$3.29Mperiod ending
Latest reported$3.29Mperiod ending
HQL Quarterly SG&A Expenses ($0.00 → $3.29M)
Quarterly SG&A Expenses
High-resolution chart · PNG
HQL sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 3,287,317 | |
| 743,171 | |
| 2,737,107 | |
| 3,181,733 | |
| 2,718,600 | |
| -1,966,881 | |
| 2,870,019 | |
| 1,442,964 | |
| 1,562 | |
| 1,648 | |
| 1,565 | |
| 1,431 | |
| 1,322 | |
| 2,631,170 | |
| 2,688,454 | |
| 2,815,402 | |
| 2,777,532 | |
| 2,990 | |
| 2,571 | |
| 2,479 | |
| 2,749 | |
| 3,174 | |
| 2,871 | |
| 2,402 | |
| 2,240 | |
| 1,919 | |
| 884 | |
| 1,850,738 | |
| 1,577,180 | |
| 575,000 | |
| 575,000 | |
| 315,000 | |
| 315,000 | |
| 295,000 | |
| 295,000 | |
| 340,000 | |
| 340,000 | |
| 360,000 | |
| 360,000 | |
| 275,000 | |
| 275,000 | |
| 255,000 | |
| 255,000 | |
| 265,000 | |
| 265,000 | |
| 225,000 | |
| 225,000 | |
| 235,000 | |
| 235,000 | |
| 170,000 | |
| 170,000 | |
| 115,000 | |
| 115,000 | |
| 95,000 | |
| 95,000 | |
| 0 | |
| 0 |